Results 161 to 170 of about 70,756 (309)

The Prevalence and Severity of Acquired Blepharoptosis in US Eye Care Clinic Patients and Their Receptivity to Treatment

open access: yesClinical Ophthalmology
Cynthia Matossian Matossian Eye Associates, Doylestown, PA, USACorrespondence: Cynthia Matossian, 3096 Comfort Road, New Hope, Doylestown, PA, 18938, USA, Tel +1 215-208-6944, Email cmatossianmd@icloud.comPurpose: To assess the presence and severity of ...
Matossian C
doaj  

Giant jelly bump deposits on therapeutic contact lens: an unusual finding following ptosis surgery [PDF]

open access: bronze, 2022
Ayushi Agarwal   +3 more
openalex   +1 more source

Expanding the Genetic and Phenotypic Spectrum of POLRMT‐Related Mitochondrial Disease

open access: yesClinical Genetics, Volume 109, Issue 1, Page 167-175, January 2026.
We identified potentially damaging monoallelic and biallelic POLRMT variants in affected individuals from six unrelated families, thus extending both the clinical and genetic phenotypes of POLRMT‐related mitochondrial disease. ABSTRACT Mitochondrial diseases are a complex group of conditions exhibiting significant phenotypic and genetic heterogeneity ...
Mahmoud R. Fassad   +20 more
wiley   +1 more source

Can atogepant be a preventive treatment for cluster headache?—Insights from a case series

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 336-340, January 2026.
Abstract Cluster headache (CH) is a disabling primary headache disorder with limited therapeutic options. Calcitonin gene‐related peptide (CGRP) is known to be involved in CH pathophysiology; however, except for galcanezumab (300 mg) in episodic CH, anti‐CGRP monoclonal antibodies did not reduce CH attacks in randomized clinical trials. Atogepant is an
Catarina Serrão   +3 more
wiley   +1 more source

Abstract QS25: The Impact of Ptosis, Breast Size, and Surgical History on Complications in Autologous Breast Reconstruction

open access: gold, 2019
Jeffrey N. Li   +6 more
openalex   +1 more source

Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Botulinum toxin type A (BoNT‐A) is widely recognized as the leading nonsurgical cosmetic treatment worldwide for diminishing dynamic wrinkles in the glabellar, forehead, and periorbital areas. While BoNT‐A is widely acknowledged for its effectiveness and popularity, there are notable inconsistencies in results, methodologies, and ...
Alaa Safia   +4 more
wiley   +1 more source

Mastering Midface Rejuvenation: A Proposal for a New Three‐Layer, Ultrasound‐Guided Technique

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Introduction Aging affects all facial layers: deep fat atrophy reduces midface projection, superficial fat changes alter facial contour, and dermal thinning compromises skin texture. Midface rejuvenation aims to restore malar projection, cheek volume, and youthful contours, thereby improving the nasolabial fold and suborbicular region ...
Paola Molinari   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy